TH

Tony Ho

GB Garnet Biotherapeutics: 4 patents #3 of 10Top 30%
AA Astrazeneca Ab: 1 patents #1,022 of 1,971Top 55%
CA Crispr Therapeutics Ag: 1 patents #35 of 72Top 50%
JM John Hopkins University, School Of Medicine: 1 patents #7 of 55Top 15%
VI Vertex Pharmaceuticals Incorporated: 1 patents #683 of 896Top 80%
📍 Wilmington, DE: #611 of 3,182 inventorsTop 20%
🗺 Delaware: #1,197 of 7,163 inventorsTop 20%
Overall (All Time): #617,156 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12161674 CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof Ewelina Morawa, Tirtha Chakraborty, Ante Sven Lundberg, Laura Sandler, Brenda Eustace +2 more 2024-12-10
11389481 Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19 Mark Benton, Demetrios Kalaitzidis, Ewelina Morawa, Jonathan Alexander Terrett 2022-07-19
10351826 Cell populations which co-express CD49c and CD90 Gene Kopen, William Righter, J. Rutkowski, Joseph Wagner 2019-07-16
9969977 Cell populations which co-express CD49c and CD90 Gene Kopen, William Righter, J. Rutkowski, Joseph Wagner, W. Herring +1 more 2018-05-15
9969980 Cell populations which co-express CD49c and CD90 Gene Kopen, William Righter, J. Rutkowski, Joseph Wagner 2018-05-15
9475773 NK3 receptor antagonist compound (NK3RA) for use in a method for the treatment of polycystic ovary syndrome (PCOS) Peter Stewart Gilmour, Rahul Kakkar, Lorraine Webber 2016-10-25
8486696 Cell populations which co-express CD49c and CD90 Gene Kopen, William Righter, J. Rutkowski, Joseph Wagner 2013-07-16
6812248 Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes Yuesheng ZHANG, Yun Li 2004-11-02